Atreca Expands Leadership Team, Appoints Industry Leader Susan Berland As Executive Vice President And Chief Financial Officer

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, today announced that Susan Berland has been appointed to the newly created position of Executive Vice President and Chief Financial Officer. Ms. Berland brings to Atreca over 20 years’ experience in financial and operational management at both large, public multinational firms and private life science companies. Ms. Berland will report directly to Tito A. Serafini, Ph.D., Atreca’s President, Chief Executive Officer, and Co-Founder, and her appointment is effective immediately.